Related content

Understanding and Applying Personalized Therapeutics at Systems Level:Role for Translational Bioinformatics

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 2, 2011-06 ,pp. : 137-147

Bentham Science Publishers

Access to resources Recommend Favorite

From personalized medicine to personalized justice: the promises of translational pharmacogenomics in the justice system

By Wong Steven HY   Happy Christopher   Blinka Dan   Gock Susan   Jentzen Jeffrey M   Donald Hon. Joseph   Coleman Howard   Jortani Saeed A   Lucire Yolande   Morris-Kukoski Cynthia L   Neuman Manuela G   Orsulak Paul J   Sander Tara   Wagner Michael A   Wynn Jennifer R   Wu Alan HB   Yeo Kiang-Teck J  

Pharmacogenomics, Vol. 11, Iss. 6, 2010-06 ,pp. : 731-737

Future Medicine

Access to resources Recommend Favorite

Practical Challenges and Translational Issues in Pharmacogenomics and Personalized Medicine from 2010 Onwards

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 14, Iss. 1, 2017-01 ,pp. : 7-17

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Features, Markers, Drug Targets, and Prospective Targeted Therapeutics in Cardiac Myxoma

By  

Current Cancer Drug Targets, Vol. 9, Iss. 6, 2009-09 ,pp. : 705-716

Bentham Science Publishers

Access to resources Recommend Favorite

Economic and Cost-Effectiveness Considerations for Pharmacogenetics Tests: An Integral Part of Translational Research and Innovation Uptake in Personalized Medicine

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 7, Iss. 4, 2009-12 ,pp. : 284-296

Bentham Science Publishers

Access to resources Recommend Favorite